p53 protein is absent from the serum of patients with lung cancer
1996

p53 Protein Levels in Lung Cancer Patients' Serum

Sample size: 114 publication Evidence: high

Author Information

Author(s): MA Levesque, M D'Costa, EP Diamandis

Primary Institution: Mount Sinai Hospital, University of Toronto, St Joseph's Health Centre

Hypothesis

Can p53 protein be detected in the serum of lung cancer patients?

Conclusion

The study found that p53 protein is not present in the serum of lung cancer patients.

Supporting Evidence

  • Only two out of 216 serum samples from lung cancer patients showed detectable p53 protein levels.
  • None of the control sera from healthy individuals or patients with non-malignant lung diseases had detectable p53 protein.
  • The presence of p53 protein in the serum could not be correlated with tumor characteristics.

Takeaway

Doctors looked for a protein called p53 in the blood of lung cancer patients but found it was mostly not there, suggesting it doesn't show up in blood like they thought.

Methodology

The study used a quantitative immunoassay to measure p53 protein concentrations in serum and matched lung tumor tissues from lung cancer patients.

Potential Biases

Potential interference from heterophilic antibodies in serum could lead to false-positive results.

Limitations

The study could not determine if p53 levels declined after surgery due to the absence of detectable serum p53 protein.

Participant Demographics

The study included 114 lung cancer patients, consisting of 23 males and 52 females, with ages ranging from less than 59 to over 80 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication